Business
Covalon Granted Key Antimicrobial Patents in the United States, Canada, and Europe
Covalon Granted Key Antimicrobial Patents in the United States, Canada, and Europe ...
About this update from Covalon Technologies Ltd.
[{"type":"text","content":"\n\n\n\nCovalon Granted Key Antimicrobial Patents in the United States, Canada, and Europe\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMISSISSAUGA, ON, June 3, 2020\n\n\n\nMISSISSAUGA, ON, June 3, 2020 /CNW/ - Covalon Technologies Ltd. (the \"Company\" or \"Covalon\") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that the Company has been granted key antimicrobial patents by the United States Patent and Trademark Office (\"USPTO\"), the Canadian Intellectual Property Office (\"CIPO\"), and the European Patent Office (\"EPO\").  \n\n \n \n \n \n \n \n\n \nCovalon's Antimicrobial Silicone-based Wound Dressing patent has been granted in the United States by the USPTO, in Canada by the CIPO, and in Europe by the EPO. This antimicrobial patent is integral to the Company's CovaClear® platform technology and the Company's IV Clear®, MediClear® PreOp, and SurgiClear® products. \nThe USPTO also granted the Company a patent for a Method for the Reduction of Microbial Skin Flora, which protects the Company's novel product MediClear PreOp. MediClear PreOp is indicated for use as a pre-operative drape that provides continuous antimicrobial activity to reduce the risk of contamination of the skin prior to a surgical procedure. \n\"This is a major accomplishment to protect the only dual-antimicrobial silicone adhesive technology on the market,\" said Brian Pedlar, Covalon's Chief Executive Officer. \"We are very pleased to see that the United States, Canadian, and European patent offices have all recognized Covalon's innovations in antimicrobial technologies through the granting of these patents. Protecting patients from infection during hospital procedures is a significant growth opportunity and these patents solidify Covalon's advantage in this market.\" \nIV Clear® is the only dual-antimicrobial fully transparent silicone vascular access dressing on the market. The patented technology incorporates chlorohexidine and silver into the entire surface area of the adhesive, ensuring the greate...